BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 22900509)

  • 1. Socioeconomic and educational factors interference in the prognosis for glioblastoma multiform.
    Lynch JC; Welling L; Escosteguy C; Pereira AG; Andrade R; Pereira C
    Br J Neurosurg; 2013 Feb; 27(1):80-3. PubMed ID: 22900509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of survival between cerebellar and supratentorial glioblastoma patients: surveillance, epidemiology, and end results (SEER) analysis.
    Jeswani S; Nuño M; Folkerts V; Mukherjee D; Black KL; Patil CG
    Neurosurgery; 2013 Aug; 73(2):240-6; discussion 246; quiz 246. PubMed ID: 23615082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of sex and the presence of giant cells on postoperative long-term survival in adult patients with supratentorial glioblastoma multiforme.
    Shinojima N; Kochi M; Hamada J; Nakamura H; Yano S; Makino K; Tsuiki H; Tada K; Kuratsu J; Ishimaru Y; Ushio Y
    J Neurosurg; 2004 Aug; 101(2):219-26. PubMed ID: 15309911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supratentorial glioblastoma treated with radiotherapy: use of the Radiation Therapy Oncology Group recursive partitioning analysis grouping for predicting survival.
    Fujii O; Soejima T; Kuwatsuka Y; Harada A; Ota Y; Tsujino K; Sasaki M; Kudo H; Nishihara M; Taomoto K
    Jpn J Clin Oncol; 2010 Aug; 40(8):726-31. PubMed ID: 20410057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I/II trial of hyperfractionated concomitant boost proton radiotherapy for supratentorial glioblastoma multiforme.
    Mizumoto M; Tsuboi K; Igaki H; Yamamoto T; Takano S; Oshiro Y; Hayashi Y; Hashii H; Kanemoto A; Nakayama H; Sugahara S; Sakurai H; Matsumura A; Tokuuye K
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):98-105. PubMed ID: 19695794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy in supratentorial gliomas. A study of 821 cases.
    Heesters M; Molenaar W; Go GK
    Strahlenther Onkol; 2003 Sep; 179(9):606-14. PubMed ID: 14628126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.
    Marina O; Suh JH; Reddy CA; Barnett GH; Vogelbaum MA; Peereboom DM; Stevens GH; Elinzano H; Chao ST
    J Neurosurg; 2011 Aug; 115(2):220-9. PubMed ID: 21548745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution.
    Mohan DS; Suh JH; Phan JL; Kupelian PA; Cohen BH; Barnett GH
    Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):981-7. PubMed ID: 9869219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of neuronavigation and image-guided extensive resection for adult patients with supratentorial malignant astrocytomas: a single-institution retrospective study.
    Kurimoto M; Hayashi N; Kamiyama H; Nagai S; Shibata T; Asahi T; Matsumura N; Hirashima Y; Endo S
    Minim Invasive Neurosurg; 2004 Oct; 47(5):278-83. PubMed ID: 15578340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome and prognostic factors in adult cerebellar glioblastoma.
    Babu R; Sharma R; Karikari IO; Owens TR; Friedman AH; Adamson C
    J Clin Neurosci; 2013 Aug; 20(8):1117-21. PubMed ID: 23706183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical prognostic factors of adult supratentorial glioblastoma].
    Jiang HH; Ren XH; Cui Y; Li MX; Yang KY; Lei YF; Lin S
    Zhonghua Wai Ke Za Zhi; 2019 May; 57(5):377-382. PubMed ID: 31091594
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
    Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality-adjusted survival after tumor resection and/or radiation therapy for elderly patients with glioblastoma multiforme.
    Muacevic A; Kreth FW
    J Neurol; 2003 May; 250(5):561-8. PubMed ID: 12736735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors influencing clinical outcomes of glioblastoma multiforme.
    Li SW; Qiu XG; Chen BS; Zhang W; Ren H; Wang ZC; Jiang T
    Chin Med J (Engl); 2009 Jun; 122(11):1245-9. PubMed ID: 19567131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II trial of accelerated radiotherapy using weekly stereotactic conformal boost for supratentorial glioblastoma multiforme: RTOG 0023.
    Cardinale R; Won M; Choucair A; Gillin M; Chakravarti A; Schultz C; Souhami L; Chen A; Pham H; Mehta M
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1422-8. PubMed ID: 16750317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of eligible patients with supratentorial glioblastoma multiforme for gross total resection.
    Shinoda J; Sakai N; Murase S; Yano H; Matsuhisa T; Funakoshi T
    J Neurooncol; 2001 Apr; 52(2):161-71. PubMed ID: 11508816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can MRI-derived factors predict the survival in glioblastoma patients treated with postoperative chemoradiation therapy?
    Nakamura H; Murakami R; Hirai T; Kitajima M; Yamashita Y
    Acta Radiol; 2013 Mar; 54(2):214-20. PubMed ID: 23138021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical analysis of the fatal cases of adult malignant gliomas after aggressive treatment].
    Takamura Y; Ibayashi Y; Morimoto S; Tanabe S; Hashi K
    No Shinkei Geka; 1994 Mar; 22(3):207-13. PubMed ID: 8133960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme.
    Helseth R; Helseth E; Johannesen TB; Langberg CW; Lote K; Rønning P; Scheie D; Vik A; Meling TR
    Acta Neurol Scand; 2010 Sep; 122(3):159-67. PubMed ID: 20298491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
    Vordermark D; Ruprecht K; Rieckmann P; Roggendorf W; Vince GH; Warmuth-Metz M; Kölbl O; Flentje M
    BMC Cancer; 2006 Oct; 6():247. PubMed ID: 17049083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.